Fig. 6

Comparison of duration of morning stiffness between IGU therapy and other DMARDs monotherapy (primarily comprising MTX). IGU, iguratimod; MTX, methotrexate; DMARDs, disease-modifying antirheumatic drugs
Comparison of duration of morning stiffness between IGU therapy and other DMARDs monotherapy (primarily comprising MTX). IGU, iguratimod; MTX, methotrexate; DMARDs, disease-modifying antirheumatic drugs